CYP2C8
Showing 1 - 25 of >10,000
Healthy Adults Trial in Dallas (Treatment A, Treatment B)
Not yet recruiting
- Healthy Adults
- Treatment A
- Treatment B
-
Dallas, TexasLabcorp Clinical Research Unit Inc
May 11, 2023
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)
Recruiting
- GIST - Gastrointestinal Stromal Tumor
-
Jacksonville, Florida
- +2 more
Mar 7, 2022
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York
Completed
- Diffuse Large B Cell Lymphoma
- +4 more
- Tazemetostat
- +3 more
-
Tucson, Arizona
- +2 more
Mar 23, 2021
Adverse Events in Cancer and Without Liver Impairment
Recruiting
- Liver Diseases
- Blood samples
-
Cairo, Abbasia, EgyptEl Demerdash Oncology Hospital
Apr 27, 2021
Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant Trial in Bauru
Completed
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
-
Bauru, São Paulo, BrazilBauru School of Dentistry/USP
Nov 2, 2020
Prostate Cancer Patients Trial in Changsha (Repaglinide, Bupropion and SHR3680)
Recruiting
- Prostate Cancer Patients
- Repaglinide, Bupropion and SHR3680
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Dec 7, 2020
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in
Not yet recruiting
- Polymorphism, Genetic
- +5 more
- (no location specified)
Nov 3, 2023
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population
Completed
- Healthy Volunteers
- Ibuprofen
-
Rawalpindi, Punjab, PakistanAmmarah Amjad
Aug 1, 2023
Healthy Trial in Rennes (Drug Cocktail, Foliglurax, midazolam iv)
Completed
- Healthy
- Drug Cocktail
- +2 more
-
Rennes, FranceBiotrial
Apr 22, 2020
Health Volunteers Trial in Miami (CTP-543, Fluconazole)
Recruiting
- Health Volunteers
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Jul 26, 2022
CYP2C19 Genetic Variants Trial in Stanford (Limonene)
Recruiting
- CYP2C19 Genetic Variants
- Limonene
-
Stanford, CaliforniaStanford School of Medicine
Aug 18, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Healthy Trial (Voriconazole 200mg, FluvoxaMINE 50 Mg Oral Tablet, Omeprazole 10 MG Oral Tablet)
Not yet recruiting
- Healthy
- Voriconazole 200mg
- +2 more
- (no location specified)
Feb 21, 2022
Genotyping Techniques Trial in Ottawa (Spartan Cube CYP2C19 System)
Completed
- Genotyping Techniques
- Spartan Cube CYP2C19 System
-
Ottawa, Ontario, Canada
- +2 more
Jul 15, 2020
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023